NO20002191L - Dofetilid polymorfer - Google Patents

Dofetilid polymorfer

Info

Publication number
NO20002191L
NO20002191L NO20002191A NO20002191A NO20002191L NO 20002191 L NO20002191 L NO 20002191L NO 20002191 A NO20002191 A NO 20002191A NO 20002191 A NO20002191 A NO 20002191A NO 20002191 L NO20002191 L NO 20002191L
Authority
NO
Norway
Prior art keywords
polymorphs
dofetilide polymorphs
dofetilide
processes
preparation
Prior art date
Application number
NO20002191A
Other languages
English (en)
Other versions
NO325630B1 (no
NO20002191D0 (no
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nichols
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002191(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO20002191L publication Critical patent/NO20002191L/no
Publication of NO20002191D0 publication Critical patent/NO20002191D0/no
Publication of NO325630B1 publication Critical patent/NO325630B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Oppfinnelsen vedrører de hovedsakelige rene dofetilid polymorfer P162, P162a og P143, og fremgangsmåter for fremstillingen av, sammensetninger inneholdende og an-vendelsene av, slike polymorfer.
NO20002191A 1997-10-27 2000-04-27 Dofetilidpolymorf, fremgangsmate for fremstilling derav samt anvendelse derav for fremstilling av medikamenter og medisinske preparater. NO325630B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs
PCT/EP1998/006641 WO1999021829A1 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Publications (3)

Publication Number Publication Date
NO20002191L true NO20002191L (no) 2000-04-27
NO20002191D0 NO20002191D0 (no) 2000-04-27
NO325630B1 NO325630B1 (no) 2008-06-30

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002191A NO325630B1 (no) 1997-10-27 2000-04-27 Dofetilidpolymorf, fremgangsmate for fremstilling derav samt anvendelse derav for fremstilling av medikamenter og medisinske preparater.

Country Status (46)

Country Link
US (1) US6124363A (no)
EP (1) EP1027329B1 (no)
JP (1) JP3569495B2 (no)
KR (1) KR100366167B1 (no)
CN (1) CN1146537C (no)
AP (1) AP906A (no)
AR (1) AR015193A1 (no)
AT (1) ATE232199T1 (no)
AU (1) AU737668B2 (no)
BG (1) BG64125B1 (no)
BR (1) BR9813308A (no)
CA (1) CA2307121C (no)
CO (1) CO4970768A1 (no)
DE (1) DE69811256T2 (no)
DK (1) DK1027329T3 (no)
DZ (1) DZ2632A1 (no)
EA (1) EA002656B1 (no)
ES (1) ES2190620T3 (no)
GB (1) GB9722662D0 (no)
GT (1) GT199800165A (no)
HN (1) HN1998000165A (no)
HR (1) HRP20000247B1 (no)
HU (1) HUP0004735A3 (no)
ID (1) ID24658A (no)
IL (1) IL135435A0 (no)
IS (1) IS2179B (no)
MA (1) MA24683A1 (no)
MY (1) MY123352A (no)
NO (1) NO325630B1 (no)
NZ (1) NZ503785A (no)
OA (1) OA11350A (no)
PA (1) PA8462001A1 (no)
PE (1) PE122199A1 (no)
PL (1) PL197379B1 (no)
PT (1) PT1027329E (no)
SA (1) SA98190834B1 (no)
SI (1) SI1027329T1 (no)
SK (1) SK5862000A3 (no)
TN (1) TNSN98193A1 (no)
TR (1) TR200001135T2 (no)
TW (1) TW449589B (no)
UA (1) UA67755C2 (no)
UY (2) UY25222A1 (no)
WO (1) WO1999021829A1 (no)
YU (1) YU24000A (no)
ZA (1) ZA989719B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ2017772A3 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
PE122199A1 (es) 1999-12-02
EA200000365A1 (ru) 2000-12-25
JP2001521023A (ja) 2001-11-06
UA67755C2 (uk) 2004-07-15
WO1999021829A1 (en) 1999-05-06
UY25222A1 (es) 2000-12-29
DK1027329T3 (da) 2003-02-24
EA002656B1 (ru) 2002-08-29
HK1033933A1 (en) 2001-10-05
CA2307121C (en) 2006-12-05
YU24000A (sh) 2003-02-28
US6124363A (en) 2000-09-26
UY25341A1 (es) 1999-09-27
CN1146537C (zh) 2004-04-21
HUP0004735A3 (en) 2001-12-28
HRP20000247B1 (en) 2002-08-31
IL135435A0 (en) 2001-05-20
SK5862000A3 (en) 2001-10-08
EP1027329B1 (en) 2003-02-05
EP1027329A1 (en) 2000-08-16
CA2307121A1 (en) 1999-05-06
GT199800165A (es) 2000-04-19
IS5426A (is) 2000-03-31
HN1998000165A (es) 1999-02-09
PL197379B1 (pl) 2008-03-31
PA8462001A1 (es) 2000-05-24
DE69811256T2 (de) 2003-09-18
NZ503785A (en) 2004-11-26
KR100366167B1 (ko) 2003-01-09
ATE232199T1 (de) 2003-02-15
BG64125B1 (bg) 2004-01-30
AR015193A1 (es) 2001-04-18
AU2151299A (en) 1999-05-17
NO325630B1 (no) 2008-06-30
CO4970768A1 (es) 2000-11-07
AP9801371A0 (en) 1998-12-31
KR20010031439A (ko) 2001-04-16
SI1027329T1 (en) 2003-04-30
IS2179B (is) 2006-12-15
GB9722662D0 (en) 1997-12-24
ID24658A (id) 2000-07-27
DE69811256D1 (de) 2003-03-13
BR9813308A (pt) 2000-08-22
AU737668B2 (en) 2001-08-30
TNSN98193A1 (fr) 2005-03-15
TR200001135T2 (tr) 2000-09-21
SA98190834B1 (ar) 2006-08-21
ES2190620T3 (es) 2003-08-01
BG104373A (en) 2000-12-29
HUP0004735A2 (hu) 2001-10-28
OA11350A (en) 2003-12-17
NO20002191D0 (no) 2000-04-27
MA24683A1 (fr) 1999-07-01
TW449589B (en) 2001-08-11
AP906A (en) 2000-11-30
HRP20000247A2 (en) 2000-10-31
CN1278246A (zh) 2000-12-27
PL340805A1 (en) 2001-02-26
PT1027329E (pt) 2003-04-30
DZ2632A1 (fr) 2003-03-08
MY123352A (en) 2006-05-31
JP3569495B2 (ja) 2004-09-22
ZA989719B (en) 2000-04-26

Similar Documents

Publication Publication Date Title
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
PT934325E (pt) Trisanidridos biciclicos de tetrafosfonato
ES2195970T3 (es) L-ribavirina y usos de la misma.
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
BG103485A (en) Ketobanzamides as calpain inhibitors
MY113806A (en) Antiparasitic marcfortines and paraherquamides
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
YU2500A (sh) Alatrofloksacin parenteralni preparati
NO20002191L (no) Dofetilid polymorfer
HU9500559D0 (en) New mercapto-acetamide tricyclic derivatives as enkephalinase-inhibitors
CA2166692A1 (en) Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
MX9801190A (es) Inhibidores de prolil endopeptidasa.
SE9604582D0 (sv) Novel compounds
BG100248A (bg) Инхибитори на скваленсинтетаза
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
GR3034406T3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
SE9603726D0 (sv) Novel compounds
TW282449B (no)
IL119412A (en) Gonadotropins and pharmaceutical compositions containing them
ECSP982713A (es) Polimorfos de dofetilida
ES2151820A1 (es) Herbicidas a base de derivados de 1,3-oxazin-4-ona, composiciones que los contienen y procedimiento para su preparacion.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees